Last reviewed · How we verify
NCT05314829
Trauma Treatment in Norwegian Child Advocacy Centers
trial testing Trauma-focused cognitive behavioral therapy (TF-CBT) in Post Traumatic Stress Disorder in 100 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Norwegian Center for Violence and Traumatic Stress Studies |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 August 2020 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Trauma-focused cognitive behavioral therapy (TF-CBT)
Conditions studied
- Post Traumatic Stress Disorder — all drugs for Post Traumatic Stress Disorder →
Sponsor
Norwegian Center for Violence and Traumatic Stress Studies
Who can join
Adults 6 to 18, any sex, with Post Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Norwegian child and advocacy centers´ core activities include both forensic services (e.g., forensic interviews) and follow-up services (e.g., treatment), aiming to coordinate the different services involved in each case to prevent additional burdens for youth in already vulnerable situations. However, a recent study indicates that very few receive follow-up after the forensic interview and that the follow-up in most cases includes one-time or occasional support and only in rare cases treatment. In the same study, youth receiving follow-up in the CAC in Oslo revealed significantly higher levels of common mental health problems than a comparable community sample, yet lower than clinical samples, indicating that many youths in CACs may be falling between different services within the health care system, not necessarily receiving the help they need elsewhere. The current project will investigate four issues related to these knowledge needs; 1. How do children and parents experience receiving trauma treatment at child advocacy centers? 2. What predicts treatment effects? 3. What is the prevalence of symptoms of burnout and secondary traumatic stress among employees working in child advocacy centers, and can training in evidence-based treatment prevent burnout and secondary traumatic stress?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05314829
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Trauma-focused cognitive behavioral therapy (TF-CBT)
Trials testing the same drug.
- NCT05226481 — Investigating the Effect of Evidence-based Treatment for Post-traumatic Stress Disorder Among Youth · completed
- NCT05248971 — Implementation of Truma-Focused Cognitive Behavioral Therapy (TF-CBT) in Norway · completed
Other recruiting trials for Post Traumatic Stress Disorder
Currently open trials in the same condition.
- NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
- NCT07316088 — Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms · Phase 2 · recruiting
- NCT07227337 — Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study · NA · recruiting
- NCT06988787 — Multifaceted Intervention to Restore Resilience and Overcome Risk · NA · recruiting
- NCT06740487 — Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder · NA · recruiting
Other Norwegian Center for Violence and Traumatic Stress Studies trials
Trials by the same sponsor.
- NCT06592677 — Early Support After Exposure to Trauma · NA · recruiting
- NCT05734547 — Stepping Together for Children After Trauma, Norway · NA · recruiting
- NCT05042323 — Short-term Intervention and Health Trajectories After Mass Trauma · NA · completed
- NCT04735328 — Implementering PTSD Treatment · NA · unknown
- NCT04336605 — Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adoles · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05314829 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Norwegian Center for Violence and Traumatic Stress Studies
- Last refreshed: 30 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05314829.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing